Upgrade to SI Premium - Free Trial

BMO Capital Starts Abbvie (ABBV) at Outperform; Well-Positioned to Manage Humira's LOE

November 18, 2020 4:01 AM
(Updated - November 18, 2020 6:54 AM EST)BMO Capital analyst Gary Nachman initiates coverage on Abbvie (NYSE: ABBV) with an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage